Evidence map›Paper›PMID 37770899›Full record

ArticleBMC complementary medicine and therapies2023

In vitro trypanocidal activity of extracts and compounds isolated from Vitellaria paradoxa.

Guerisson Bairy, Cyrille Oliver Ozzin-Kholy Zolipou, Romaric Nzoumbou-Boko

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Guerisson BairyDepartment of Organic Chemistry, University of Yaoundé 1, B.O Box 812, Yaoundé, Cameroon.
Cyrille Oliver Ozzin-Kholy ZolipouLaboratoire de Parasitologie, Institut Pasteur de Bangui, BP 923, Bangui, Central African Republic.
Romaric Nzoumbou-BokoLaboratoire de Parasitologie, Institut Pasteur de Bangui, BP 923, Bangui, Central African Republic. romaric.nzoumbou-boko@pasteur-bangui.cf.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVitellaria paradoxa is used in traditional medicine for the treatment of various diseases in tropical countries; however, nothing is known about its anti-trypanosomal activity. Human African trypanosomiasis is a neglected tropical disease of Sub-Saharan Africa's poorest rural regions, and the efficacy of its treatment remains a challenge. This study investigates the as-yet-unknown trypanocidal activity of this plant.

methodsV. paradoxa, commonly known as shea tree, was selected for study based on an ethnobotanical investigation. Ultrasonicated extracts from bark and seeds were successively treated with ethyl acetate and water. Column chromatography, NMR spectroscopy and mass spectrometry were used to identify isolated compounds. Purified trypanosomes (Trypanosoma brucei brucei) were incubated with serial dilutions of the extracts and isolated compounds at 37 °C in 5% CO

resultsThe ethyl acetate extracts of the bark showed the higher in vitro trypanocidal activity against T. brucei brucei with median inhibitory concentration (IC

conclusionThe results obtained contribute to the validation of the traditional medicinal use of V. paradoxa. Our results encourage further investigations of this plant, mainly with respect to its in vivo efficacy and toxicity.

Indexed as

Plants, MedicinalTrypanocidal AgentsTrypanosoma brucei bruceiAcetatesHumansPlant ExtractsAcetatesethyl acetatePlant ExtractsTrypanocidal AgentsIn vitroTrypanocidal activityTrypanosoma brucei bruceiVitellaria paradoxa

Identifiers

PMID37770899
PMCPMC10540432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.